Investing Profile

Brent Ahrens

VCInvestor
General Partner at Canaan Partners
canaan.com/team/brent-ahrensMenlo Park, California
Photo of Brent Ahrens, General Partner at Canaan Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Canaan Partners General Partner
$250K - $20.0M
$10.0M
47
$800M
CompanyStageDateRound SizeTotal Raised
Grey Wolf Therapeutics
Series BMay 2024$50M
Series BJan 2023$49M
Series AJan 2020$3M
Series AFeb 2019$13M
$120M
illumicell AI
Pre SeedNov 2023$300K
$300K
Relievant Medsystems
Series FOct 2020$70M
Series EJun 2018$58M
Series DOct 2016$36M
Series DMar 2012$30M
Series CJul 2009$20M
Series BOct 2006$5M
$220M
Co-investors: Jason Lettmann (Morgenthaler Ventures), Justin Klein (Vensana Capital)
EndoGastric Solutions
Series IJun 2018$41M
Series UnknownDec 2015$50M
Series GMay 2014$30M
Series UnknownJun 2012$13M
Series UnknownApr 2012$2M
Series GMar 2012$11M
Series FAug 2010$30M
$230M
Co-investors: Mike Carusi (Lightstone Ventures)
Unchained Labs
Series DMar 2018$17M
Series CJun 2017$13M
Series BFeb 2016$25M
Series AFeb 2015$25M
$80M
Iterum Therapeutics
Series BMay 2017$65M
Series AMar 2016$40M
$110M
Co-investors: Mark Chin (Arix Bioscience)
Abyrx
Series UnknownDec 2016$10M
$10M
Minimally invasive devices
Series CNov 2015$14M
Debt FinancingJun 2014$6M
Series BJun 2013$3M
Series BMar 2013$9M
$32M
Co-investors: Wende Hutton (Canaan Partners)